The Universities of Edinburgh and Glasgow established the Scottish Genomes Partnership with a £15m investment.
10 state-of-the-art Illumina HiSeq X genome sequencing instruments were installed at their sequencing hubs. These are Edinburgh Genomics and the Translational Research Centre at the Wolfson Wohl Cancer Research Centre.
The Scottish Genomes Partnership received £6m in research funding from Scotland’s Chief Scientist Office (£4m) and the UK’s Medical Research Council (£2m), creating a pan-Scotland research partnership.
This funding has brought significant research opportunities, including major collaborations with Genomics England and AstraZeneca.
In its initial phase, scientists have been exploring causes of central nervous system disorders, developmental disorders, and cancer, as well as examining genes which influence risk factors for common, complex diseases in a Scottish population.
The Scottish Government announced a £4.2m investment in genomics services as part of its Programme for Government 2018-19.